Calando Obtains Patent Rights To Rnai Technology In China - Congoo

|

|

News

Media & Advertising

Calando obtains patent rights to RNAi technology in China

Have an interest in this Story?
Sign Up for Real-Time email updates

Datamonitor | May 14, 2008

Calando Pharmaceuticals, a majority owned subsidiary of Arrowhead Research Corporation, has announced the issuance of Chinese patent for therapeutic use of RNA interference.The Chinese patent broadly covers all methods of using any RNA interference ('RNAi') construct formulated in a supramolecular c...

Read Full Article

Leave a Comment:

You must be logged in to leave a comment Log in | Register

Most Read World Articles

Fitzgibbon wants brief on nerve gas plan - The Age

Bush to meet Manmohan during G-8 summit in Japan - Press Trust of India

Health Tip: Have a Safe Fourth of July - HealthScout

G8 leaders face series of crises - BBC

Shell ready to quit Zimbabwe as Mugabe cronies hoard fuel - Guardian Unlimited

Featured Members

Jaime Neyra Morales
Relationship Manager, Commercial Banking
Banking

Matthew Clark
Mentor
Entrepreneur

View more profiles

Access dozens of premium and subscriptions sites Free! Download now.

Advertise | Build a News Circle | Get News Briefings | Congoo News Home | Get the Netpass

About Congoo | Terms | Privacy | Need Help? | Site Map

Copyright ©2008 Congoo.com. All Rights Reserved.